Royalty Pharma PLC (RPRX)
27.61
+0.14
(+0.51%)
USD |
NASDAQ |
Apr 17, 16:00
27.61
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Price to Book Value: 1.890 for April 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 16, 2024 | 1.880 |
| April 15, 2024 | 1.934 |
| April 12, 2024 | 1.932 |
| April 11, 2024 | 1.988 |
| April 10, 2024 | 2.016 |
| April 09, 2024 | 2.034 |
| April 08, 2024 | 2.001 |
| April 05, 2024 | 1.998 |
| April 04, 2024 | 1.966 |
| April 03, 2024 | 1.971 |
| April 02, 2024 | 2.015 |
| April 01, 2024 | 2.046 |
| March 28, 2024 | 2.079 |
| March 27, 2024 | 2.084 |
| March 26, 2024 | 2.069 |
| March 25, 2024 | 2.072 |
| March 22, 2024 | 2.072 |
| March 21, 2024 | 2.083 |
| March 20, 2024 | 2.081 |
| March 19, 2024 | 2.066 |
| March 18, 2024 | 2.057 |
| March 15, 2024 | 2.059 |
| March 14, 2024 | 2.043 |
| March 13, 2024 | 2.045 |
| March 12, 2024 | 2.077 |
| Date | Value |
|---|---|
| March 11, 2024 | 2.059 |
| March 08, 2024 | 2.079 |
| March 07, 2024 | 2.056 |
| March 06, 2024 | 2.036 |
| March 05, 2024 | 2.014 |
| March 04, 2024 | 2.046 |
| March 01, 2024 | 2.048 |
| February 29, 2024 | 2.077 |
| February 28, 2024 | 2.095 |
| February 27, 2024 | 2.142 |
| February 26, 2024 | 2.144 |
| February 23, 2024 | 2.124 |
| February 22, 2024 | 2.123 |
| February 21, 2024 | 2.138 |
| February 20, 2024 | 2.074 |
| February 16, 2024 | 2.048 |
| February 15, 2024 | 2.055 |
| February 14, 2024 | 2.005 |
| February 13, 2024 | 2.006 |
| February 12, 2024 | 1.988 |
| February 09, 2024 | 2.003 |
| February 08, 2024 | 1.964 |
| February 07, 2024 | 2.007 |
| February 06, 2024 | 2.066 |
| February 05, 2024 | 1.897 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.877
Minimum
Sep 21 2023
4.324
Maximum
Dec 29 2020
2.938
Average
2.987
Median
Price to Book Value Benchmarks
| Viatris Inc | 0.6434 |
| Walgreens Boots Alliance Inc | 1.127 |
| Pacira BioSciences Inc | 1.431 |
| Amphastar Pharmaceuticals Inc | 3.016 |
| Maravai LifeSciences Holdings Inc | 2.451 |
Price to Book Value Related Metrics
| PE Ratio | 10.96 |
| PS Ratio | 7.070 |
| Price to Free Cash Flow | 5.572 |
| Price | 27.61 |
| Earnings Yield | 9.13% |
| Market Cap | 12.33B |
| Operating PE Ratio | 11.16 |
| Normalized PE Ratio | 13.84 |